Summary
Results with a 28 to 30 day’s oral treatment of postmenopausal women with 4 mg estriol, 2 mg estrone, 2 mg free estradiol, 2 mg estradiol-17α-valerate, 1,25 mg and 0,3 mg conjugated estrogens and 50, 100 and 200 μg l-Hydroxy-ethinylestradiol-1.3-diacetate are indicating a divergence of the peripheral and the central antigonadotrophic activity of different estrogens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Hilgar, G., and J. Palmore jr.: Uterotropic Bioassay Data. Issue III of Endocrine Bioassay Data (1968).
Rosemberg, E., u. I. Engel: J. clin. Endocr. 20, 1576 (1960).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Laschet, U., Laschet, L. (1969). Klinische Untersuchungen über die antigonadotrope Wirkung von Oestrogenen. In: Kracht, J. (eds) Oestrogene Hypophysentumoren. Oestrogene Hypophysentumoren, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95126-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-95126-8_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-95127-5
Online ISBN: 978-3-642-95126-8
eBook Packages: Springer Book Archive